Conexeu Sciences is trading 7.16% down at $9.28, with the move appearing catalyst-unclear.

  • It reversed the August 18, 2026 close of $9.99; no new company-specific announcement, filing, or direct catalyst for the August 19 decline was identified.
  • August 18 company news discussed regenerative medical aesthetics research, not adverse developments.
  • Biotech is broadly stronger, with XBI up 3.73%, and major U.S. indexes are higher, so broader direction does not explain the decline.